ArticleEuropean journal of medical research2025
Novel hypoxia-immune biomarkers predict response to neoadjuvant chemotherapy in patients with laryngo-hypopharyngeal cancer.
Lingwa Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.